Q&A: How FDA decision is speeding development of new osteoporosis drugs
Osteoporosis weakens bones and makes them more likely to break. The disease affects about 10 million Americans over age 50, including one in five women. And those numbers are expected to rise as the share of Americans 65 and older climbs from 18.9% to 23.4% by 2060.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Traumatic brain injury can alter the brain's subsequent response to stress, study shows
United Kingdom
-
Universal germline genetic testing catches missed cancer risks in older patients
United Kingdom
-
Olive oil before carbs blunts early blood sugar rise in mice
United Kingdom
-
Value-aligned messages increased COVID-19 vaccination intentions, study finds
United Kingdom
-
Vaccination protects the immune system from long-term infection damage
United Kingdom
-
FDA-approved epilepsy drug may help reverse osteoarthritis damage
United States
-
Why muscle health should be a bigger part of clinical nutrition
United Kingdom
-
Endless video feeds leave users with ADHD struggling to stop, survey finds
United Kingdom